LUNG CANCER-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=999411, encodeId=1917999411b2, content=submit to journal已经10天了依然没变化，请问是必须所有作者通过邮件确认才会进入下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ba45548781, createdName=Chloezzx, createdTime=Wed Jul 14 15:13:33 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196266, encodeId=999d219626613, content=2023-11底投稿，2024-01送审，2024-03-26拒稿，慢，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33006457091, createdName=ms7000000319608821, createdTime=Sat Mar 30 23:43:09 CST 2024, time=2024-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146481, encodeId=c43b214648139, content=with editor 10天还没到动静！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07e52540181, createdName=1251d3b4m35暂无昵称, createdTime=Wed Jul 05 16:49:44 CST 2023, time=2023-07-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153885, encodeId=16972153885eb, content=with editor 16 天了，大家都等了多久，要不要催一下呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81236447731, createdName=ms4000000409769509, createdTime=Mon Aug 21 16:08:58 CST 2023, time=2023-08-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=469552, encodeId=fca546955213, content=专业领域：肿瘤 杂志国家：英国 投稿年份：2007 审稿周期: 6weeks 是否经历大小修：一次小修 从开始投稿到接受（拒稿）多长时间：60 days 期间是否要求润色语言：否 是否收版面费：否 个人评述（感受或经验）：审稿效率高，编辑的水平较高在送到reviewer 之前很多编辑便可以给出很准确的判断，或者直接拒稿本人投过2个稿子一个小修，另一个直接拒掉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medison, createdTime=Tue Dec 15 09:59:00 CST 2009, time=2009-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469677, encodeId=70294696e738, content=投稿日期：2008.10.20 投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接）：http://ees.elsevier.com/lungcancer/default.asp 修回日期：2008.11.13拒稿 修改方式（大修，小修，拒稿）：拒稿 Thank you for submitting your manuscript to Lung Cancer, which has now been reviewed by our international experts. Based on their recommendations and after careful deliberations, we regret to advise you that we have decided not to publish your contribution in the journal. I have enclosed some reviewer comments, which you might find useful should you resubmit your paper elsewhere. 接受日期：否 是否收版面费：否 分享的经验或教训： 1 Elsvier投稿系统，效率较高，编辑也比较负责任，投稿第二天就Under Review，三个星期审完，两天Dicision。 2 被拒原因：很多细节问题没有注意。 3 虽然被拒，但是个人觉得这个杂志稍微有新意就有希望，难度不大，而且审稿快，IF也不低，值得考虑。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CANCER, createdTime=Tue Dec 15 12:45:00 CST 2009, time=2009-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544947, encodeId=9f7f54494e3b, content=审稿速度:2.0 经验分享：我在2017年5月9日投稿了一篇meta分析，是按照original research 投稿的。6月7日要求大修，7月3日修回。7月19日要求小修，7月21日修回，7月24日接受。7月29日杂志官网就已经挂出来了，，而且是original research，速度挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9acd1468957, createdName=wangzili83, createdTime=Mon Jul 31 09:44:00 CST 2017, time=2017-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552125, encodeId=462b55212541, content=想请问下lung cancer杂志的with editor的时间持续多久？我的都几乎10天了，还没送审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLc3PoqaNe4QU1p2A4AgKFSQqTcyUR9FjWf6ADSvlmlo14JoBKFWuOJM2ZxbdTZY5ibWcymibCia49dg/132, createdBy=94d32257781, createdName=xiaofeilian, createdTime=Mon Jan 29 15:32:00 CST 2018, time=2018-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144656, encodeId=9d68214465617, content=有没有前辈有经验 Lung cancer对于偏生信分析结合临床样本类的文章接受度如何？（非预后模型类的文章，多组学方向）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ae8659435, createdName=ms6000000997003486, createdTime=Sun Jun 25 14:39:11 CST 2023, time=2023-06-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2089440, encodeId=2e432089440e2, content=有没有懂哥解答下：submitted to the journal 状态是不是需要所有作者通过邮件确认才能下一步啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1456199563, createdName=169745_8068, createdTime=Tue Sep 20 23:35:22 CST 2022, time=2022-09-20, status=1, ipAttribution=)]

2021-07-14 Chloezzx

submit to journal已经10天了依然没变化，请问是必须所有作者通过邮件确认才会进入下一步吗？

154 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=999411, encodeId=1917999411b2, content=submit to journal已经10天了依然没变化，请问是必须所有作者通过邮件确认才会进入下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ba45548781, createdName=Chloezzx, createdTime=Wed Jul 14 15:13:33 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196266, encodeId=999d219626613, content=2023-11底投稿，2024-01送审，2024-03-26拒稿，慢，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33006457091, createdName=ms7000000319608821, createdTime=Sat Mar 30 23:43:09 CST 2024, time=2024-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146481, encodeId=c43b214648139, content=with editor 10天还没到动静！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07e52540181, createdName=1251d3b4m35暂无昵称, createdTime=Wed Jul 05 16:49:44 CST 2023, time=2023-07-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153885, encodeId=16972153885eb, content=with editor 16 天了，大家都等了多久，要不要催一下呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81236447731, createdName=ms4000000409769509, createdTime=Mon Aug 21 16:08:58 CST 2023, time=2023-08-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=469552, encodeId=fca546955213, content=专业领域：肿瘤 杂志国家：英国 投稿年份：2007 审稿周期: 6weeks 是否经历大小修：一次小修 从开始投稿到接受（拒稿）多长时间：60 days 期间是否要求润色语言：否 是否收版面费：否 个人评述（感受或经验）：审稿效率高，编辑的水平较高在送到reviewer 之前很多编辑便可以给出很准确的判断，或者直接拒稿本人投过2个稿子一个小修，另一个直接拒掉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medison, createdTime=Tue Dec 15 09:59:00 CST 2009, time=2009-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469677, encodeId=70294696e738, content=投稿日期：2008.10.20 投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接）：http://ees.elsevier.com/lungcancer/default.asp 修回日期：2008.11.13拒稿 修改方式（大修，小修，拒稿）：拒稿 Thank you for submitting your manuscript to Lung Cancer, which has now been reviewed by our international experts. Based on their recommendations and after careful deliberations, we regret to advise you that we have decided not to publish your contribution in the journal. I have enclosed some reviewer comments, which you might find useful should you resubmit your paper elsewhere. 接受日期：否 是否收版面费：否 分享的经验或教训： 1 Elsvier投稿系统，效率较高，编辑也比较负责任，投稿第二天就Under Review，三个星期审完，两天Dicision。 2 被拒原因：很多细节问题没有注意。 3 虽然被拒，但是个人觉得这个杂志稍微有新意就有希望，难度不大，而且审稿快，IF也不低，值得考虑。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CANCER, createdTime=Tue Dec 15 12:45:00 CST 2009, time=2009-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544947, encodeId=9f7f54494e3b, content=审稿速度:2.0 经验分享：我在2017年5月9日投稿了一篇meta分析，是按照original research 投稿的。6月7日要求大修，7月3日修回。7月19日要求小修，7月21日修回，7月24日接受。7月29日杂志官网就已经挂出来了，，而且是original research，速度挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9acd1468957, createdName=wangzili83, createdTime=Mon Jul 31 09:44:00 CST 2017, time=2017-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552125, encodeId=462b55212541, content=想请问下lung cancer杂志的with editor的时间持续多久？我的都几乎10天了，还没送审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLc3PoqaNe4QU1p2A4AgKFSQqTcyUR9FjWf6ADSvlmlo14JoBKFWuOJM2ZxbdTZY5ibWcymibCia49dg/132, createdBy=94d32257781, createdName=xiaofeilian, createdTime=Mon Jan 29 15:32:00 CST 2018, time=2018-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144656, encodeId=9d68214465617, content=有没有前辈有经验 Lung cancer对于偏生信分析结合临床样本类的文章接受度如何？（非预后模型类的文章，多组学方向）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ae8659435, createdName=ms6000000997003486, createdTime=Sun Jun 25 14:39:11 CST 2023, time=2023-06-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2089440, encodeId=2e432089440e2, content=有没有懂哥解答下：submitted to the journal 状态是不是需要所有作者通过邮件确认才能下一步啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1456199563, createdName=169745_8068, createdTime=Tue Sep 20 23:35:22 CST 2022, time=2022-09-20, status=1, ipAttribution=)]

2024-03-30 ms7000000319608821 来自江苏省

2023-11底投稿，2024-01送审，2024-03-26拒稿，慢，慎投

41 0

[GetPortalCommentsPageByObjectIdResponse(id=999411, encodeId=1917999411b2, content=submit to journal已经10天了依然没变化，请问是必须所有作者通过邮件确认才会进入下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ba45548781, createdName=Chloezzx, createdTime=Wed Jul 14 15:13:33 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196266, encodeId=999d219626613, content=2023-11底投稿，2024-01送审，2024-03-26拒稿，慢，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33006457091, createdName=ms7000000319608821, createdTime=Sat Mar 30 23:43:09 CST 2024, time=2024-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146481, encodeId=c43b214648139, content=with editor 10天还没到动静！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07e52540181, createdName=1251d3b4m35暂无昵称, createdTime=Wed Jul 05 16:49:44 CST 2023, time=2023-07-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153885, encodeId=16972153885eb, content=with editor 16 天了，大家都等了多久，要不要催一下呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81236447731, createdName=ms4000000409769509, createdTime=Mon Aug 21 16:08:58 CST 2023, time=2023-08-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=469552, encodeId=fca546955213, content=专业领域：肿瘤 杂志国家：英国 投稿年份：2007 审稿周期: 6weeks 是否经历大小修：一次小修 从开始投稿到接受（拒稿）多长时间：60 days 期间是否要求润色语言：否 是否收版面费：否 个人评述（感受或经验）：审稿效率高，编辑的水平较高在送到reviewer 之前很多编辑便可以给出很准确的判断，或者直接拒稿本人投过2个稿子一个小修，另一个直接拒掉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medison, createdTime=Tue Dec 15 09:59:00 CST 2009, time=2009-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469677, encodeId=70294696e738, content=投稿日期：2008.10.20 投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接）：http://ees.elsevier.com/lungcancer/default.asp 修回日期：2008.11.13拒稿 修改方式（大修，小修，拒稿）：拒稿 Thank you for submitting your manuscript to Lung Cancer, which has now been reviewed by our international experts. Based on their recommendations and after careful deliberations, we regret to advise you that we have decided not to publish your contribution in the journal. I have enclosed some reviewer comments, which you might find useful should you resubmit your paper elsewhere. 接受日期：否 是否收版面费：否 分享的经验或教训： 1 Elsvier投稿系统，效率较高，编辑也比较负责任，投稿第二天就Under Review，三个星期审完，两天Dicision。 2 被拒原因：很多细节问题没有注意。 3 虽然被拒，但是个人觉得这个杂志稍微有新意就有希望，难度不大，而且审稿快，IF也不低，值得考虑。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CANCER, createdTime=Tue Dec 15 12:45:00 CST 2009, time=2009-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544947, encodeId=9f7f54494e3b, content=审稿速度:2.0 经验分享：我在2017年5月9日投稿了一篇meta分析，是按照original research 投稿的。6月7日要求大修，7月3日修回。7月19日要求小修，7月21日修回，7月24日接受。7月29日杂志官网就已经挂出来了，，而且是original research，速度挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9acd1468957, createdName=wangzili83, createdTime=Mon Jul 31 09:44:00 CST 2017, time=2017-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552125, encodeId=462b55212541, content=想请问下lung cancer杂志的with editor的时间持续多久？我的都几乎10天了，还没送审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLc3PoqaNe4QU1p2A4AgKFSQqTcyUR9FjWf6ADSvlmlo14JoBKFWuOJM2ZxbdTZY5ibWcymibCia49dg/132, createdBy=94d32257781, createdName=xiaofeilian, createdTime=Mon Jan 29 15:32:00 CST 2018, time=2018-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144656, encodeId=9d68214465617, content=有没有前辈有经验 Lung cancer对于偏生信分析结合临床样本类的文章接受度如何？（非预后模型类的文章，多组学方向）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ae8659435, createdName=ms6000000997003486, createdTime=Sun Jun 25 14:39:11 CST 2023, time=2023-06-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2089440, encodeId=2e432089440e2, content=有没有懂哥解答下：submitted to the journal 状态是不是需要所有作者通过邮件确认才能下一步啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1456199563, createdName=169745_8068, createdTime=Tue Sep 20 23:35:22 CST 2022, time=2022-09-20, status=1, ipAttribution=)]

2023-07-05 1251d3b4m35暂无昵称来自辽宁省

with editor 10天还没到动静！

92 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=999411, encodeId=1917999411b2, content=submit to journal已经10天了依然没变化，请问是必须所有作者通过邮件确认才会进入下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ba45548781, createdName=Chloezzx, createdTime=Wed Jul 14 15:13:33 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196266, encodeId=999d219626613, content=2023-11底投稿，2024-01送审，2024-03-26拒稿，慢，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33006457091, createdName=ms7000000319608821, createdTime=Sat Mar 30 23:43:09 CST 2024, time=2024-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146481, encodeId=c43b214648139, content=with editor 10天还没到动静！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07e52540181, createdName=1251d3b4m35暂无昵称, createdTime=Wed Jul 05 16:49:44 CST 2023, time=2023-07-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153885, encodeId=16972153885eb, content=with editor 16 天了，大家都等了多久，要不要催一下呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81236447731, createdName=ms4000000409769509, createdTime=Mon Aug 21 16:08:58 CST 2023, time=2023-08-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=469552, encodeId=fca546955213, content=专业领域：肿瘤 杂志国家：英国 投稿年份：2007 审稿周期: 6weeks 是否经历大小修：一次小修 从开始投稿到接受（拒稿）多长时间：60 days 期间是否要求润色语言：否 是否收版面费：否 个人评述（感受或经验）：审稿效率高，编辑的水平较高在送到reviewer 之前很多编辑便可以给出很准确的判断，或者直接拒稿本人投过2个稿子一个小修，另一个直接拒掉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medison, createdTime=Tue Dec 15 09:59:00 CST 2009, time=2009-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469677, encodeId=70294696e738, content=投稿日期：2008.10.20 投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接）：http://ees.elsevier.com/lungcancer/default.asp 修回日期：2008.11.13拒稿 修改方式（大修，小修，拒稿）：拒稿 Thank you for submitting your manuscript to Lung Cancer, which has now been reviewed by our international experts. Based on their recommendations and after careful deliberations, we regret to advise you that we have decided not to publish your contribution in the journal. I have enclosed some reviewer comments, which you might find useful should you resubmit your paper elsewhere. 接受日期：否 是否收版面费：否 分享的经验或教训： 1 Elsvier投稿系统，效率较高，编辑也比较负责任，投稿第二天就Under Review，三个星期审完，两天Dicision。 2 被拒原因：很多细节问题没有注意。 3 虽然被拒，但是个人觉得这个杂志稍微有新意就有希望，难度不大，而且审稿快，IF也不低，值得考虑。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CANCER, createdTime=Tue Dec 15 12:45:00 CST 2009, time=2009-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544947, encodeId=9f7f54494e3b, content=审稿速度:2.0 经验分享：我在2017年5月9日投稿了一篇meta分析，是按照original research 投稿的。6月7日要求大修，7月3日修回。7月19日要求小修，7月21日修回，7月24日接受。7月29日杂志官网就已经挂出来了，，而且是original research，速度挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9acd1468957, createdName=wangzili83, createdTime=Mon Jul 31 09:44:00 CST 2017, time=2017-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552125, encodeId=462b55212541, content=想请问下lung cancer杂志的with editor的时间持续多久？我的都几乎10天了，还没送审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLc3PoqaNe4QU1p2A4AgKFSQqTcyUR9FjWf6ADSvlmlo14JoBKFWuOJM2ZxbdTZY5ibWcymibCia49dg/132, createdBy=94d32257781, createdName=xiaofeilian, createdTime=Mon Jan 29 15:32:00 CST 2018, time=2018-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144656, encodeId=9d68214465617, content=有没有前辈有经验 Lung cancer对于偏生信分析结合临床样本类的文章接受度如何？（非预后模型类的文章，多组学方向）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ae8659435, createdName=ms6000000997003486, createdTime=Sun Jun 25 14:39:11 CST 2023, time=2023-06-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2089440, encodeId=2e432089440e2, content=有没有懂哥解答下：submitted to the journal 状态是不是需要所有作者通过邮件确认才能下一步啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1456199563, createdName=169745_8068, createdTime=Tue Sep 20 23:35:22 CST 2022, time=2022-09-20, status=1, ipAttribution=)]

2023-08-21 ms4000000409769509 来自江苏省

with editor 16 天了，大家都等了多久，要不要催一下呢

96 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=999411, encodeId=1917999411b2, content=submit to journal已经10天了依然没变化，请问是必须所有作者通过邮件确认才会进入下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ba45548781, createdName=Chloezzx, createdTime=Wed Jul 14 15:13:33 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196266, encodeId=999d219626613, content=2023-11底投稿，2024-01送审，2024-03-26拒稿，慢，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33006457091, createdName=ms7000000319608821, createdTime=Sat Mar 30 23:43:09 CST 2024, time=2024-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146481, encodeId=c43b214648139, content=with editor 10天还没到动静！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07e52540181, createdName=1251d3b4m35暂无昵称, createdTime=Wed Jul 05 16:49:44 CST 2023, time=2023-07-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153885, encodeId=16972153885eb, content=with editor 16 天了，大家都等了多久，要不要催一下呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81236447731, createdName=ms4000000409769509, createdTime=Mon Aug 21 16:08:58 CST 2023, time=2023-08-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=469552, encodeId=fca546955213, content=专业领域：肿瘤 杂志国家：英国 投稿年份：2007 审稿周期: 6weeks 是否经历大小修：一次小修 从开始投稿到接受（拒稿）多长时间：60 days 期间是否要求润色语言：否 是否收版面费：否 个人评述（感受或经验）：审稿效率高，编辑的水平较高在送到reviewer 之前很多编辑便可以给出很准确的判断，或者直接拒稿本人投过2个稿子一个小修，另一个直接拒掉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medison, createdTime=Tue Dec 15 09:59:00 CST 2009, time=2009-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469677, encodeId=70294696e738, content=投稿日期：2008.10.20 投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接）：http://ees.elsevier.com/lungcancer/default.asp 修回日期：2008.11.13拒稿 修改方式（大修，小修，拒稿）：拒稿 Thank you for submitting your manuscript to Lung Cancer, which has now been reviewed by our international experts. Based on their recommendations and after careful deliberations, we regret to advise you that we have decided not to publish your contribution in the journal. I have enclosed some reviewer comments, which you might find useful should you resubmit your paper elsewhere. 接受日期：否 是否收版面费：否 分享的经验或教训： 1 Elsvier投稿系统，效率较高，编辑也比较负责任，投稿第二天就Under Review，三个星期审完，两天Dicision。 2 被拒原因：很多细节问题没有注意。 3 虽然被拒，但是个人觉得这个杂志稍微有新意就有希望，难度不大，而且审稿快，IF也不低，值得考虑。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CANCER, createdTime=Tue Dec 15 12:45:00 CST 2009, time=2009-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544947, encodeId=9f7f54494e3b, content=审稿速度:2.0 经验分享：我在2017年5月9日投稿了一篇meta分析，是按照original research 投稿的。6月7日要求大修，7月3日修回。7月19日要求小修，7月21日修回，7月24日接受。7月29日杂志官网就已经挂出来了，，而且是original research，速度挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9acd1468957, createdName=wangzili83, createdTime=Mon Jul 31 09:44:00 CST 2017, time=2017-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552125, encodeId=462b55212541, content=想请问下lung cancer杂志的with editor的时间持续多久？我的都几乎10天了，还没送审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLc3PoqaNe4QU1p2A4AgKFSQqTcyUR9FjWf6ADSvlmlo14JoBKFWuOJM2ZxbdTZY5ibWcymibCia49dg/132, createdBy=94d32257781, createdName=xiaofeilian, createdTime=Mon Jan 29 15:32:00 CST 2018, time=2018-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144656, encodeId=9d68214465617, content=有没有前辈有经验 Lung cancer对于偏生信分析结合临床样本类的文章接受度如何？（非预后模型类的文章，多组学方向）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ae8659435, createdName=ms6000000997003486, createdTime=Sun Jun 25 14:39:11 CST 2023, time=2023-06-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2089440, encodeId=2e432089440e2, content=有没有懂哥解答下：submitted to the journal 状态是不是需要所有作者通过邮件确认才能下一步啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1456199563, createdName=169745_8068, createdTime=Tue Sep 20 23:35:22 CST 2022, time=2022-09-20, status=1, ipAttribution=)]

2009-12-15 medison

专业领域：肿瘤

杂志国家：英国
投稿年份：2007
审稿周期: 6weeks
是否经历大小修：一次小修
从开始投稿到接受（拒稿）多长时间：60 days
期间是否要求润色语言：否
是否收版面费：否
个人评述（感受或经验）：审稿效率高，编辑的水平较高在送到reviewer 之前很多编辑便可以给出很准确的判断，或者直接拒稿本人投过2个稿子一个小修，另一个直接拒掉。

359 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=999411, encodeId=1917999411b2, content=submit to journal已经10天了依然没变化，请问是必须所有作者通过邮件确认才会进入下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ba45548781, createdName=Chloezzx, createdTime=Wed Jul 14 15:13:33 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196266, encodeId=999d219626613, content=2023-11底投稿，2024-01送审，2024-03-26拒稿，慢，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33006457091, createdName=ms7000000319608821, createdTime=Sat Mar 30 23:43:09 CST 2024, time=2024-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146481, encodeId=c43b214648139, content=with editor 10天还没到动静！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07e52540181, createdName=1251d3b4m35暂无昵称, createdTime=Wed Jul 05 16:49:44 CST 2023, time=2023-07-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153885, encodeId=16972153885eb, content=with editor 16 天了，大家都等了多久，要不要催一下呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81236447731, createdName=ms4000000409769509, createdTime=Mon Aug 21 16:08:58 CST 2023, time=2023-08-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=469552, encodeId=fca546955213, content=专业领域：肿瘤 杂志国家：英国 投稿年份：2007 审稿周期: 6weeks 是否经历大小修：一次小修 从开始投稿到接受（拒稿）多长时间：60 days 期间是否要求润色语言：否 是否收版面费：否 个人评述（感受或经验）：审稿效率高，编辑的水平较高在送到reviewer 之前很多编辑便可以给出很准确的判断，或者直接拒稿本人投过2个稿子一个小修，另一个直接拒掉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medison, createdTime=Tue Dec 15 09:59:00 CST 2009, time=2009-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469677, encodeId=70294696e738, content=投稿日期：2008.10.20 投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接）：http://ees.elsevier.com/lungcancer/default.asp 修回日期：2008.11.13拒稿 修改方式（大修，小修，拒稿）：拒稿 Thank you for submitting your manuscript to Lung Cancer, which has now been reviewed by our international experts. Based on their recommendations and after careful deliberations, we regret to advise you that we have decided not to publish your contribution in the journal. I have enclosed some reviewer comments, which you might find useful should you resubmit your paper elsewhere. 接受日期：否 是否收版面费：否 分享的经验或教训： 1 Elsvier投稿系统，效率较高，编辑也比较负责任，投稿第二天就Under Review，三个星期审完，两天Dicision。 2 被拒原因：很多细节问题没有注意。 3 虽然被拒，但是个人觉得这个杂志稍微有新意就有希望，难度不大，而且审稿快，IF也不低，值得考虑。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CANCER, createdTime=Tue Dec 15 12:45:00 CST 2009, time=2009-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544947, encodeId=9f7f54494e3b, content=审稿速度:2.0 经验分享：我在2017年5月9日投稿了一篇meta分析，是按照original research 投稿的。6月7日要求大修，7月3日修回。7月19日要求小修，7月21日修回，7月24日接受。7月29日杂志官网就已经挂出来了，，而且是original research，速度挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9acd1468957, createdName=wangzili83, createdTime=Mon Jul 31 09:44:00 CST 2017, time=2017-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552125, encodeId=462b55212541, content=想请问下lung cancer杂志的with editor的时间持续多久？我的都几乎10天了，还没送审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLc3PoqaNe4QU1p2A4AgKFSQqTcyUR9FjWf6ADSvlmlo14JoBKFWuOJM2ZxbdTZY5ibWcymibCia49dg/132, createdBy=94d32257781, createdName=xiaofeilian, createdTime=Mon Jan 29 15:32:00 CST 2018, time=2018-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144656, encodeId=9d68214465617, content=有没有前辈有经验 Lung cancer对于偏生信分析结合临床样本类的文章接受度如何？（非预后模型类的文章，多组学方向）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ae8659435, createdName=ms6000000997003486, createdTime=Sun Jun 25 14:39:11 CST 2023, time=2023-06-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2089440, encodeId=2e432089440e2, content=有没有懂哥解答下：submitted to the journal 状态是不是需要所有作者通过邮件确认才能下一步啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1456199563, createdName=169745_8068, createdTime=Tue Sep 20 23:35:22 CST 2022, time=2022-09-20, status=1, ipAttribution=)]

2009-12-15 CANCER

投稿日期：2008.10.20
投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接）：http://ees.elsevier.com/lungcancer/default.asp
修回日期：2008.11.13拒稿
修改方式（大修，小修，拒稿）：拒稿
Thank you for submitting your manuscript to Lung Cancer, which has now been reviewed by our international experts. Based on their recommendations and after careful deliberations, we regret to advise you that we have decided not to publish your contribution in the journal. I have enclosed some reviewer comments, which you might find useful should you resubmit your paper elsewhere.
接受日期：否
是否收版面费：否
分享的经验或教训：
1 Elsvier投稿系统，效率较高，编辑也比较负责任，投稿第二天就Under Review，三个星期审完，两天Dicision。
2 被拒原因：很多细节问题没有注意。
3 虽然被拒，但是个人觉得这个杂志稍微有新意就有希望，难度不大，而且审稿快，IF也不低，值得考虑。

362 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=999411, encodeId=1917999411b2, content=submit to journal已经10天了依然没变化，请问是必须所有作者通过邮件确认才会进入下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ba45548781, createdName=Chloezzx, createdTime=Wed Jul 14 15:13:33 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196266, encodeId=999d219626613, content=2023-11底投稿，2024-01送审，2024-03-26拒稿，慢，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33006457091, createdName=ms7000000319608821, createdTime=Sat Mar 30 23:43:09 CST 2024, time=2024-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146481, encodeId=c43b214648139, content=with editor 10天还没到动静！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07e52540181, createdName=1251d3b4m35暂无昵称, createdTime=Wed Jul 05 16:49:44 CST 2023, time=2023-07-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153885, encodeId=16972153885eb, content=with editor 16 天了，大家都等了多久，要不要催一下呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81236447731, createdName=ms4000000409769509, createdTime=Mon Aug 21 16:08:58 CST 2023, time=2023-08-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=469552, encodeId=fca546955213, content=专业领域：肿瘤 杂志国家：英国 投稿年份：2007 审稿周期: 6weeks 是否经历大小修：一次小修 从开始投稿到接受（拒稿）多长时间：60 days 期间是否要求润色语言：否 是否收版面费：否 个人评述（感受或经验）：审稿效率高，编辑的水平较高在送到reviewer 之前很多编辑便可以给出很准确的判断，或者直接拒稿本人投过2个稿子一个小修，另一个直接拒掉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medison, createdTime=Tue Dec 15 09:59:00 CST 2009, time=2009-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469677, encodeId=70294696e738, content=投稿日期：2008.10.20 投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接）：http://ees.elsevier.com/lungcancer/default.asp 修回日期：2008.11.13拒稿 修改方式（大修，小修，拒稿）：拒稿 Thank you for submitting your manuscript to Lung Cancer, which has now been reviewed by our international experts. Based on their recommendations and after careful deliberations, we regret to advise you that we have decided not to publish your contribution in the journal. I have enclosed some reviewer comments, which you might find useful should you resubmit your paper elsewhere. 接受日期：否 是否收版面费：否 分享的经验或教训： 1 Elsvier投稿系统，效率较高，编辑也比较负责任，投稿第二天就Under Review，三个星期审完，两天Dicision。 2 被拒原因：很多细节问题没有注意。 3 虽然被拒，但是个人觉得这个杂志稍微有新意就有希望，难度不大，而且审稿快，IF也不低，值得考虑。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CANCER, createdTime=Tue Dec 15 12:45:00 CST 2009, time=2009-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544947, encodeId=9f7f54494e3b, content=审稿速度:2.0 经验分享：我在2017年5月9日投稿了一篇meta分析，是按照original research 投稿的。6月7日要求大修，7月3日修回。7月19日要求小修，7月21日修回，7月24日接受。7月29日杂志官网就已经挂出来了，，而且是original research，速度挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9acd1468957, createdName=wangzili83, createdTime=Mon Jul 31 09:44:00 CST 2017, time=2017-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552125, encodeId=462b55212541, content=想请问下lung cancer杂志的with editor的时间持续多久？我的都几乎10天了，还没送审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLc3PoqaNe4QU1p2A4AgKFSQqTcyUR9FjWf6ADSvlmlo14JoBKFWuOJM2ZxbdTZY5ibWcymibCia49dg/132, createdBy=94d32257781, createdName=xiaofeilian, createdTime=Mon Jan 29 15:32:00 CST 2018, time=2018-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144656, encodeId=9d68214465617, content=有没有前辈有经验 Lung cancer对于偏生信分析结合临床样本类的文章接受度如何？（非预后模型类的文章，多组学方向）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ae8659435, createdName=ms6000000997003486, createdTime=Sun Jun 25 14:39:11 CST 2023, time=2023-06-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2089440, encodeId=2e432089440e2, content=有没有懂哥解答下：submitted to the journal 状态是不是需要所有作者通过邮件确认才能下一步啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1456199563, createdName=169745_8068, createdTime=Tue Sep 20 23:35:22 CST 2022, time=2022-09-20, status=1, ipAttribution=)]

2017-07-31 wangzili83

审稿速度:2.0
经验分享：我在2017年5月9日投稿了一篇meta分析，是按照original research 投稿的。6月7日要求大修，7月3日修回。7月19日要求小修，7月21日修回，7月24日接受。7月29日杂志官网就已经挂出来了，，而且是original research，速度挺快的。

312 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=999411, encodeId=1917999411b2, content=submit to journal已经10天了依然没变化，请问是必须所有作者通过邮件确认才会进入下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ba45548781, createdName=Chloezzx, createdTime=Wed Jul 14 15:13:33 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196266, encodeId=999d219626613, content=2023-11底投稿，2024-01送审，2024-03-26拒稿，慢，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33006457091, createdName=ms7000000319608821, createdTime=Sat Mar 30 23:43:09 CST 2024, time=2024-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146481, encodeId=c43b214648139, content=with editor 10天还没到动静！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07e52540181, createdName=1251d3b4m35暂无昵称, createdTime=Wed Jul 05 16:49:44 CST 2023, time=2023-07-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153885, encodeId=16972153885eb, content=with editor 16 天了，大家都等了多久，要不要催一下呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81236447731, createdName=ms4000000409769509, createdTime=Mon Aug 21 16:08:58 CST 2023, time=2023-08-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=469552, encodeId=fca546955213, content=专业领域：肿瘤 杂志国家：英国 投稿年份：2007 审稿周期: 6weeks 是否经历大小修：一次小修 从开始投稿到接受（拒稿）多长时间：60 days 期间是否要求润色语言：否 是否收版面费：否 个人评述（感受或经验）：审稿效率高，编辑的水平较高在送到reviewer 之前很多编辑便可以给出很准确的判断，或者直接拒稿本人投过2个稿子一个小修，另一个直接拒掉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medison, createdTime=Tue Dec 15 09:59:00 CST 2009, time=2009-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469677, encodeId=70294696e738, content=投稿日期：2008.10.20 投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接）：http://ees.elsevier.com/lungcancer/default.asp 修回日期：2008.11.13拒稿 修改方式（大修，小修，拒稿）：拒稿 Thank you for submitting your manuscript to Lung Cancer, which has now been reviewed by our international experts. Based on their recommendations and after careful deliberations, we regret to advise you that we have decided not to publish your contribution in the journal. I have enclosed some reviewer comments, which you might find useful should you resubmit your paper elsewhere. 接受日期：否 是否收版面费：否 分享的经验或教训： 1 Elsvier投稿系统，效率较高，编辑也比较负责任，投稿第二天就Under Review，三个星期审完，两天Dicision。 2 被拒原因：很多细节问题没有注意。 3 虽然被拒，但是个人觉得这个杂志稍微有新意就有希望，难度不大，而且审稿快，IF也不低，值得考虑。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CANCER, createdTime=Tue Dec 15 12:45:00 CST 2009, time=2009-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544947, encodeId=9f7f54494e3b, content=审稿速度:2.0 经验分享：我在2017年5月9日投稿了一篇meta分析，是按照original research 投稿的。6月7日要求大修，7月3日修回。7月19日要求小修，7月21日修回，7月24日接受。7月29日杂志官网就已经挂出来了，，而且是original research，速度挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9acd1468957, createdName=wangzili83, createdTime=Mon Jul 31 09:44:00 CST 2017, time=2017-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552125, encodeId=462b55212541, content=想请问下lung cancer杂志的with editor的时间持续多久？我的都几乎10天了，还没送审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLc3PoqaNe4QU1p2A4AgKFSQqTcyUR9FjWf6ADSvlmlo14JoBKFWuOJM2ZxbdTZY5ibWcymibCia49dg/132, createdBy=94d32257781, createdName=xiaofeilian, createdTime=Mon Jan 29 15:32:00 CST 2018, time=2018-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144656, encodeId=9d68214465617, content=有没有前辈有经验 Lung cancer对于偏生信分析结合临床样本类的文章接受度如何？（非预后模型类的文章，多组学方向）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ae8659435, createdName=ms6000000997003486, createdTime=Sun Jun 25 14:39:11 CST 2023, time=2023-06-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2089440, encodeId=2e432089440e2, content=有没有懂哥解答下：submitted to the journal 状态是不是需要所有作者通过邮件确认才能下一步啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1456199563, createdName=169745_8068, createdTime=Tue Sep 20 23:35:22 CST 2022, time=2022-09-20, status=1, ipAttribution=)]

2018-01-29 xiaofeilian

想请问下lung cancer杂志的with editor的时间持续多久？我的都几乎10天了，还没送审。

355 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=999411, encodeId=1917999411b2, content=submit to journal已经10天了依然没变化，请问是必须所有作者通过邮件确认才会进入下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ba45548781, createdName=Chloezzx, createdTime=Wed Jul 14 15:13:33 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196266, encodeId=999d219626613, content=2023-11底投稿，2024-01送审，2024-03-26拒稿，慢，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33006457091, createdName=ms7000000319608821, createdTime=Sat Mar 30 23:43:09 CST 2024, time=2024-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146481, encodeId=c43b214648139, content=with editor 10天还没到动静！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07e52540181, createdName=1251d3b4m35暂无昵称, createdTime=Wed Jul 05 16:49:44 CST 2023, time=2023-07-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153885, encodeId=16972153885eb, content=with editor 16 天了，大家都等了多久，要不要催一下呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81236447731, createdName=ms4000000409769509, createdTime=Mon Aug 21 16:08:58 CST 2023, time=2023-08-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=469552, encodeId=fca546955213, content=专业领域：肿瘤 杂志国家：英国 投稿年份：2007 审稿周期: 6weeks 是否经历大小修：一次小修 从开始投稿到接受（拒稿）多长时间：60 days 期间是否要求润色语言：否 是否收版面费：否 个人评述（感受或经验）：审稿效率高，编辑的水平较高在送到reviewer 之前很多编辑便可以给出很准确的判断，或者直接拒稿本人投过2个稿子一个小修，另一个直接拒掉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medison, createdTime=Tue Dec 15 09:59:00 CST 2009, time=2009-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469677, encodeId=70294696e738, content=投稿日期：2008.10.20 投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接）：http://ees.elsevier.com/lungcancer/default.asp 修回日期：2008.11.13拒稿 修改方式（大修，小修，拒稿）：拒稿 Thank you for submitting your manuscript to Lung Cancer, which has now been reviewed by our international experts. Based on their recommendations and after careful deliberations, we regret to advise you that we have decided not to publish your contribution in the journal. I have enclosed some reviewer comments, which you might find useful should you resubmit your paper elsewhere. 接受日期：否 是否收版面费：否 分享的经验或教训： 1 Elsvier投稿系统，效率较高，编辑也比较负责任，投稿第二天就Under Review，三个星期审完，两天Dicision。 2 被拒原因：很多细节问题没有注意。 3 虽然被拒，但是个人觉得这个杂志稍微有新意就有希望，难度不大，而且审稿快，IF也不低，值得考虑。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CANCER, createdTime=Tue Dec 15 12:45:00 CST 2009, time=2009-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544947, encodeId=9f7f54494e3b, content=审稿速度:2.0 经验分享：我在2017年5月9日投稿了一篇meta分析，是按照original research 投稿的。6月7日要求大修，7月3日修回。7月19日要求小修，7月21日修回，7月24日接受。7月29日杂志官网就已经挂出来了，，而且是original research，速度挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9acd1468957, createdName=wangzili83, createdTime=Mon Jul 31 09:44:00 CST 2017, time=2017-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552125, encodeId=462b55212541, content=想请问下lung cancer杂志的with editor的时间持续多久？我的都几乎10天了，还没送审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLc3PoqaNe4QU1p2A4AgKFSQqTcyUR9FjWf6ADSvlmlo14JoBKFWuOJM2ZxbdTZY5ibWcymibCia49dg/132, createdBy=94d32257781, createdName=xiaofeilian, createdTime=Mon Jan 29 15:32:00 CST 2018, time=2018-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144656, encodeId=9d68214465617, content=有没有前辈有经验 Lung cancer对于偏生信分析结合临床样本类的文章接受度如何？（非预后模型类的文章，多组学方向）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ae8659435, createdName=ms6000000997003486, createdTime=Sun Jun 25 14:39:11 CST 2023, time=2023-06-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2089440, encodeId=2e432089440e2, content=有没有懂哥解答下：submitted to the journal 状态是不是需要所有作者通过邮件确认才能下一步啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1456199563, createdName=169745_8068, createdTime=Tue Sep 20 23:35:22 CST 2022, time=2022-09-20, status=1, ipAttribution=)]

2023-06-25 ms6000000997003486 来自辽宁省

有没有前辈有经验 Lung cancer对于偏生信分析结合临床样本类的文章接受度如何？（非预后模型类的文章，多组学方向）

88 0

[GetPortalCommentsPageByObjectIdResponse(id=999411, encodeId=1917999411b2, content=submit to journal已经10天了依然没变化，请问是必须所有作者通过邮件确认才会进入下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ba45548781, createdName=Chloezzx, createdTime=Wed Jul 14 15:13:33 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196266, encodeId=999d219626613, content=2023-11底投稿，2024-01送审，2024-03-26拒稿，慢，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33006457091, createdName=ms7000000319608821, createdTime=Sat Mar 30 23:43:09 CST 2024, time=2024-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146481, encodeId=c43b214648139, content=with editor 10天还没到动静！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07e52540181, createdName=1251d3b4m35暂无昵称, createdTime=Wed Jul 05 16:49:44 CST 2023, time=2023-07-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153885, encodeId=16972153885eb, content=with editor 16 天了，大家都等了多久，要不要催一下呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81236447731, createdName=ms4000000409769509, createdTime=Mon Aug 21 16:08:58 CST 2023, time=2023-08-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=469552, encodeId=fca546955213, content=专业领域：肿瘤 杂志国家：英国 投稿年份：2007 审稿周期: 6weeks 是否经历大小修：一次小修 从开始投稿到接受（拒稿）多长时间：60 days 期间是否要求润色语言：否 是否收版面费：否 个人评述（感受或经验）：审稿效率高，编辑的水平较高在送到reviewer 之前很多编辑便可以给出很准确的判断，或者直接拒稿本人投过2个稿子一个小修，另一个直接拒掉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medison, createdTime=Tue Dec 15 09:59:00 CST 2009, time=2009-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469677, encodeId=70294696e738, content=投稿日期：2008.10.20 投稿方式（投稿系统或者邮寄，如果有投稿系统请附上投稿链接）：http://ees.elsevier.com/lungcancer/default.asp 修回日期：2008.11.13拒稿 修改方式（大修，小修，拒稿）：拒稿 Thank you for submitting your manuscript to Lung Cancer, which has now been reviewed by our international experts. Based on their recommendations and after careful deliberations, we regret to advise you that we have decided not to publish your contribution in the journal. I have enclosed some reviewer comments, which you might find useful should you resubmit your paper elsewhere. 接受日期：否 是否收版面费：否 分享的经验或教训： 1 Elsvier投稿系统，效率较高，编辑也比较负责任，投稿第二天就Under Review，三个星期审完，两天Dicision。 2 被拒原因：很多细节问题没有注意。 3 虽然被拒，但是个人觉得这个杂志稍微有新意就有希望，难度不大，而且审稿快，IF也不低，值得考虑。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=362, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CANCER, createdTime=Tue Dec 15 12:45:00 CST 2009, time=2009-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544947, encodeId=9f7f54494e3b, content=审稿速度:2.0 经验分享：我在2017年5月9日投稿了一篇meta分析，是按照original research 投稿的。6月7日要求大修，7月3日修回。7月19日要求小修，7月21日修回，7月24日接受。7月29日杂志官网就已经挂出来了，，而且是original research，速度挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9acd1468957, createdName=wangzili83, createdTime=Mon Jul 31 09:44:00 CST 2017, time=2017-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552125, encodeId=462b55212541, content=想请问下lung cancer杂志的with editor的时间持续多久？我的都几乎10天了，还没送审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLc3PoqaNe4QU1p2A4AgKFSQqTcyUR9FjWf6ADSvlmlo14JoBKFWuOJM2ZxbdTZY5ibWcymibCia49dg/132, createdBy=94d32257781, createdName=xiaofeilian, createdTime=Mon Jan 29 15:32:00 CST 2018, time=2018-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144656, encodeId=9d68214465617, content=有没有前辈有经验 Lung cancer对于偏生信分析结合临床样本类的文章接受度如何？（非预后模型类的文章，多组学方向）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ae8659435, createdName=ms6000000997003486, createdTime=Sun Jun 25 14:39:11 CST 2023, time=2023-06-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2089440, encodeId=2e432089440e2, content=有没有懂哥解答下：submitted to the journal 状态是不是需要所有作者通过邮件确认才能下一步啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1456199563, createdName=169745_8068, createdTime=Tue Sep 20 23:35:22 CST 2022, time=2022-09-20, status=1, ipAttribution=)]

2022-09-20 169745_8068

有没有懂哥解答下：submitted to the journal 状态是不是需要所有作者通过邮件确认才能下一步啊？

141 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务